Search results :

Itraconazole

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: J02AC02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Upper respiratory tract infection 6% 7.3% x x x x x x x x x x x x x
Hyperbilirubinaemia 3% - 9% x x x x x x x x x x
Cough 0% - 10% 0% x x x x x x x x
Gastrointestinal disorder postmarketing, 4% - 12.3% x x x x x x x x x x x x x x x
Vomiting postmarketing, 0% - 10% x x x x x x x x x x x x x x x x x x
Hepatic enzyme increased postmarketing, 2.9% - 4% 0% x x x x x x x x x x
Nausea postmarketing, 0% - 15% 1.6% x x x x x x x x x x x x x x x x x x
Diarrhoea postmarketing, 1.7% - 11% 3.1% x x x x x x x x x x x x x x x x x x
Rash postmarketing, 1% - 9% x x x x x x x x x x x x x x x x x x
Serum creatinine increased 2% - 26% x x x x
Chest pain 0% - 3% x x x x x x x
Alanine aminotransferase increased 1% - 3% x x x x x x x x x
Sputum increased 1% - 3% x x x
Abdominal pain postmarketing, 0% - 7% 2.6% x x x x x x x x x x x x x x x x x x
Oedema 1% - 4% x x x x x x x x x x x x x x x x x
Fatigue postmarketing, 0% - 3% 2.6% x x x x x x x x x x x x x x
Hypertension 0% - 3% x x x x x x x x x x x x x x x
Hypokalaemia postmarketing, 0% - 29% x x x x x x x x x x x x x x x x x
Sinusitis 0% - 4% x x x x x x x x x x x x x
Skin disorder 1% - 2% x x x
Hepatic function abnormal postmarketing, 0% - 3% x x x x x x x x x x x x x x x x
Phosphatase alkaline increased 1% - 3% x x x
Pneumocystis carinii infection 0% - 2% x x x
Discomfort 1.7% 2.6% x x
Hypomagnesaemia 0% - 5% x x x x x x x x x
Bacteriuria 1.4% 1.6% x
Electrocardiogram abnormal 1.4% 1.6% x
Back pain 1.2% 2.1% x x x x
Headache postmarketing, 0% - 6% 1.6% x x x x x x x x x x x x x x x x x x
Albuminuria 1% x x x x x x x x x x
Anorexia postmarketing, 1% x x x x x x x x
Libido decreased 1% x x x x x x x
Depression 0% - 2% x x x
Dizziness postmarketing, 0% - 4% 0% x x x x x x x x x x x x x x x x x
Dyspnoea postmarketing, 0% - 5% x x x x x x x x x x x x x
Hypotension 0% - 3% x x x x x x x x x x
Orthostatic hypotension 1% x x x x x x x
Jaundice postmarketing, 0% - 2% x x x x x x x x x x x
Pain 0% - 4% x x x x x x x x x x x x x x x
Pneumonia 0% - 2% x x x
Tachycardia 0% - 3% x x x x x x x x x
Urinary tract infection 1% 0.5% x x x x x x x x
Vasculitis 1% x x x x x x x
Vertigo 1% x x x x x x x x
Sinus bradycardia 1% 0% x
Blood urea increased 0% - 7% x x x x x x x
Kidney function abnormal 0% - 12% x x x x x x
Lactic dehydrogenase activity increased 0% - 2% x x x x
Aspartate aminotransferase increased 0% - 2% x x x x x x x x x
Malaise 1% x x x x x x x
Myalgia postmarketing, 1% x x x x x x x x x x x x x x
Sweating increased 0% - 6% x x x x x x
Pharyngolaryngeal pain 1% 0.5% x
Somnolence 1% x x x x x x x x x x
Pruritus postmarketing, 1% - 3% x x x x x x x x x x x x x x x x x x
Hypocalcaemia 0% - 3% x x x x x x
Rigors 0% - 34% x x x x x x
Fluid overload 0% - 3% x x x x x
Congenital anomaly postmarketing x x x x x x x x
Alopecia postmarketing x x x x x x x x x x x x x x x x x x
Anaphylactic shock postmarketing x x x x x x x x x x x x x x x x
Angioedema postmarketing x x x x x x x x x x x x x x x x x x
Arthralgia postmarketing x x x x x x x x x
Breast disorder postmarketing x x x x x x x x x x
Connective tissue disorder postmarketing x x x x x x x x x
Constipation postmarketing, 0% - 3% x x x x x x x x x x x x x x x x x x
Dermatitis exfoliative postmarketing x x x x x x x x x x
Diplopia postmarketing x x x x x x x x x x
Dysgeusia postmarketing, 1% x x x x x x x x x x x x
Dyspepsia postmarketing x x x x x x x x x x x x x x x x
Toxic epidermal necrolysis postmarketing x x x x x x x x x x
Erythema multiforme postmarketing x x x x x x x x x x
Eye disorder postmarketing x x x x x x x x x x
Body temperature increased postmarketing, 0% - 8% x x x x x x x x x x
Cardiac disorder postmarketing x x x x x x x x x x
Cardiac failure congestive postmarketing x x x x x x x x x x x x x x x x x x
Hepatitis postmarketing x x x x x x x x x x x x x x x x
Hypersensitivity postmarketing x x x x x x x x x x x x x x x x x x
Hypertriglyceridaemia postmarketing, 3% x x x x x x x x x x x x x x x x x x
Hypoaesthesia postmarketing x x x x x x x x x x
Immune system disorder postmarketing x x x x x x x x x x
Labyrinthine disorder postmarketing x
Leukopenia postmarketing x x x x x x x x x x
Liver disorder postmarketing x
Mediastinal disorder postmarketing x x x x x x x x x x
Menstrual disorder postmarketing x x x x x x x x x x x x x x x x x x
Fungal infection postmarketing x x x
Nervous system disorder postmarketing, 1.6% x x x x x x x x x x
Neutropenia postmarketing x x x x x x x x x x x x x x x x
Pancreatitis postmarketing x x x x x x x
Paraesthesia postmarketing x x x x x x x x x x
Neuropathy peripheral postmarketing x x x x x x x x x x x x x x x x
Pulmonary oedema postmarketing x x x x x x x x x x x x x x x x x
Serum sickness postmarketing x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x x x x x x x
Thrombocytopenia postmarketing x x x x x x x x x
Onychomycosis postmarketing x x x
Tinnitus postmarketing x x x x x x x x x x x x x x x
Pollakiuria postmarketing x x x x x x x x x x
Urinary incontinence postmarketing x x x x x x x x x
Urinary tract disorder postmarketing x x x x x x x x x x x x x x x
Urticaria postmarketing, 1.2% x x x x x x x x x x x x x x x x x x
Hepatic failure postmarketing x x x x x x x x x x x x x x x x x
Oedema peripheral postmarketing x x x x x x x x x x x x x x x
Malnutrition postmarketing x x x x x x x x x x x x x
Acute hepatic failure postmarketing x x x x x x x x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x x x x x x
Hepatotoxicity postmarketing x x x x x x x x x x x x x x x x x x
Erectile dysfunction postmarketing, 1% x x x x x x x x x x x x x
Hepatobiliary disease postmarketing x x x x x x x x x x
Vision blurred postmarketing x x x x x x x x x x
Photosensitivity postmarketing x x x x x x x x x x x x
Hepatic enzyme abnormal postmarketing x
Neuropathy postmarketing x x x
Visual disturbance postmarketing x x x x x x x x x x
Drug interaction postmarketing x x x x x x x x x x x x x
Blood and lymphatic system disorders postmarketing x x x x x x x x x x
Ear and labyrinth disorders postmarketing x x x x x x x x x
Blood creatine phosphokinase increased postmarketing x x x x x
Acute generalised exanthematous pustulosis postmarketing x x x x x x x
Hepatic impairment postmarketing x
Hepatic insufficiency postmarketing x
Hearing impaired postmarketing, 3.3% 3.1% x x x x x x x x x
Renal impairment postmarketing x
Leukocytoclastic vasculitis postmarketing x x x x x x x x x x
Adrenal insufficiency x x x x x x x x x x
Agranulocytosis x
Anxiety x x x x x x x
Arrhythmia x
Asthenia x x x x x x x x x x
Mental disorder x x x x x x
Bronchospasm x
Bronchitis x
Bursitis x x x x x x x
Cardiovascular disorder x x x
Infection x x x x x
Confusional state x x x x
Cystitis x x x x x x x
Dysphagia x x x
Dehydration x x x
Drowsiness x
Encephalocele x
Flatulence x x x x x x x x x x x x x
Gastritis x x x x x x x x
Gastroenteritis x x x x x x x
Gingivitis x x x x x x x
Gynaecomastia x x x x x x x x x x
Cardiac failure x x x x
Heartburn x
Haematuria x x x
Haemorrhoids x x x
Herpes zoster x x x x x x x
Hyperglycaemia x x x x x x x
Hyperhidrosis x x x
Hyperkalaemia x x x x
Left ventricular failure x x x x
Lung disorder x
Chronic obstructive pulmonary disease x
Pharyngitis x x x x x x x x x x
Renal failure x
Rhinitis x x x x x x x x x x x x x
Ulcerative stomatitis x x x x x x x x x x
Syncope x
Tremor x x x x x x x x x x x
Angiopathy x x x x
Weight decreased x x x
Chills x x x
Hypophosphataemia x x x
Application site reaction 0% - 4% x x x
Generalised oedema x
Gamma-glutamyltransferase increased x x x x x x
Injection site inflammation x x x x
Hepatocellular injury x
Liver function test abnormal x
Increased appetite x x x x x x x
Decreased appetite x
Epigastric pain x
Teratogenicity x
Rash erythematous x x x x x x
Upset stomach x
Vein disorder 0% - 3% x x x
Breast pain male x x x x x x x x x x
Implantation complication x x x
Lung infiltration x x x
Throat sore x
Mucosal inflammation x
Anaphylactoid reaction x
Urine analysis abnormal x x x x
Face oedema x x x x
Hot flush x x x
Infestation NOS x x x
Blood alkaline phosphatase increased x x x x
Blood lactate dehydrogenase increased x x x x
Insomnia x x x x x x x x x x
Abdominal bloating x
Dysphonia x x x x
Abnormal vision x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

itraconazole / Sporanox

Side effects:52
Source:FDA

ITRACONAZOLE / SPORANOX

Side effects:54
Source:FDA

itraconazole / Sporanox

Side effects:59
Source:FDA

Itraconazole capsules / Itrazole, Capsule

Side effects:63
Source:Medsafe

ITRACONAZOLE

Side effects:78
Source:FDA Structured Product Label

ITRACONAZOLE / SPORANOX ORAL SOLUTION 10MG/ML

Side effects:80
Source:Health Canada

ITRACONAZOLE / SPORANOX

Side effects:87
Source:Health Canada

ITRACONAZOLE / SPORANOX

Side effects:92
Source:FDA

itraconazole / Sporanox

Side effects:92
Source:FDA

ITRACONAZOLE / SPORANOX

Side effects:68
Source:FDA

itraconazole / Sporanox

Side effects:67
Source:FDA

ITRACONAZOLE / SPORANOX

Side effects:69
Source:FDA

ITRACONAZOLE

Side effects:104
Source:FDA Structured Product Label

ITRACONAZOLE

Side effects:104
Source:FDA Structured Product Label

ITRACONAZOLE

Side effects:132
Source:FDA Structured Product Label

ITRACONAZOLE

Side effects:132
Source:FDA Structured Product Label

itraconazole

Side effects:136
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label